The FDA wants to pull its approval of a drug. It’s not so easy.
The US Food and Drug Administration faces a complex process when attempting to reverse its approval for a medication. Agency officials previously sought guidance from an independent advisory committee to evaluate an experimental treatment for a rare autoimmune condition affecting the kidneys and lungs.
Read More